Krilogy Financial’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-105,469
Closed -$2.63M 281
2020
Q4
$2.63M Buy
105,469
+902
+0.9% +$22.5K 0.32% 56
2020
Q3
$2.62M Sell
104,567
-21,621
-17% -$542K 0.36% 45
2020
Q2
$3.17M Buy
126,188
+62,211
+97% +$1.56M 0.49% 37
2020
Q1
$1.58M Sell
63,977
-56,068
-47% -$1.39M 0.3% 54
2019
Q4
$3M Sell
120,045
-1,039
-0.9% -$25.9K 0.49% 44
2019
Q3
$3.03M Buy
121,084
+5,578
+5% +$139K 0.55% 36
2019
Q2
$2.88M Buy
115,506
+12,146
+12% +$301K 0.55% 38
2019
Q1
$2.56M Buy
+103,360
New +$2.54M 0.54% 38

Other funds holding IBDM

Krilogy Financial's IBDM Position: Q1 2021 in Review

Krilogy Financial sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q1 2021, closing a stake of 105,469 shares — an estimated $2.63M sold.

Krilogy Financial first reported a position in IBDM in Q1 2019 and held it in 8 quarters. The position peaked at $3.17M in Q2 2020. 199 funds tracked by Wall St. Rank hold IBDM as of Q1 2021.

  • Krilogy Financial reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q1 2021 after selling out during the quarter.
  • Krilogy Financial sold 105,469 iShares iBonds Dec 2021 Term Corporate ETF shares in Q1 2021, an estimated $2.63M.
  • Krilogy Financial first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q1 2019 and held it in 8 quarters.
  • Krilogy Financial's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $3.17M in Q2 2020.
  • 199 funds tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q1 2021.

Based on Krilogy Financial's 13F filing for Q1 2021, filed 21 Apr 2021.